Trial Site Detail

 

Drug:	Nilotinib or Imatinib
Trial:	Phase III, Open-Label Study of Nilotinib Versus Imatinib in GIST Patients (ENESTg1)
Conditions:	Gastrointestinal Stromal Tumor
Trial Status:	Completed

 

Osaka University Hospital       Osaka , 565-0871 Japan

 

Principal Investigator:	Toshirou Nishida, MD
Contact:	Toshirou Nishida, MD +81-6-6879-5111 toshin@surg1.med.osaka-u.ac.jp
Activation Status of this Site:	Closed
Notes about this Site:
Osaka University Hospital Website:

 

 

Navigating the Map

Use the plus (+) and minus (-) controls to zoom in/out.

Click and drag the map or use the arrows to move (pan) the map.

Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.